Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis
Clinical trial NCT06015100 · UNKNOWN
Trial details
- NCT number
- NCT06015100
- Sponsor
- Yan Xue
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-20
- Primary completion
- 2023-08-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.